NeuroScience and Pharmasan Labs Announce Publication of Noninvasive Serotonin Assay for Depression  
12/19/2011 7:35:20 AM

OSCEOLA, Wis.--(BUSINESS WIRE)--NeuroScience, Inc., the leader in neurotransmitter testing, and Pharmasan Labs, Inc., a CLIA-accredited diagnostic laboratory, announce the publication of a peer-reviewed article in Analytical and Bioanalytical Biochemistry.

In the paper, “Evaluation of a novel ELISA for serotonin: urinary serotonin as a potential biomarker for depression”, Dr. Mikaela Nichkova and co-investigators report on the development of an enzyme-linked immunosorbent assay (ELISA) that measures the neurotransmitter, serotonin.